10% Spectinomycin sulfate + 5% inshinge ya Linomycine HCL

UMURYANGO

Buri ml irimo:

Spectinomycin (Sulfate)… 100mg

Lincomycin (HCI)… 50 mg

FORMACEUTICAL FORM:

Gutera igisubizo

GUSOBANURIRA

Ihuriro rya lincomycine na spectinomycin ikora inyongera kandi rimwe na rimwe ikomatanya.

Spectinomycin ikora bacteriostatike cyangwa bactericidal bitewe nigipimo, irwanya cyane cyane bagiteri ya Gram-mbi nka Campylobacter, E. coli na Salmonella spp.Lincomycin ikora bacteriostatike irwanya cyane cyane Gram-nziza ya bagiteri nka Mycoplasma, Treponema, staphylococcus na Streptococcus spp.Kwambukiranya lincomycine hamwe na macrolide birashobora kubaho

ICYEREKEZO

Indwara ya Gastrointestinal na respiratory yatewe na lincomycine na spectinomycine mikorobe yoroheje, nka Campylobacter, E. coli, Mycoplasma, Salmonella Staphylococcus, Streptococcus na Treponema spp.mu nyana, ihene, intama, imbwa ninjangwe.

UBURYO BWO KUBONA

Mugutera inshinge

DOSAGE:

Inyana: ml 1 kuri 10 kg uburemere bwumubiri muminsi 4.

Ihene n'intama: ml kuri kg 10 uburemere bwumubiri muminsi 3.

Injangwe n'imbwa: ml 1 kuri kg 5 uburemere bwumubiri muminsi 3-5, hamwe niminsi 21.

MU GIHE CYIZA

Inyana, ihene n'intama

Ku nyama: iminsi 14.

Amata: iminsi 3.

AMABWIRIZA

Hypersensitivite kuri lincomycine na / cyangwa spectinomycine

Ubuyobozi ku nyamaswa zifite impyiko zangiritse na / cyangwa imikorere ya hepatike

Imiyoborere ihuriweho na penisiline, cephalosporine, quinolone na

cycloserine.

INGARUKA Z'uruhande

Hypersensitivity reaction.

Nyuma gato yo gutera inshinge ububabare buke, guhinda cyangwa gucibwamo birashobora kubaho

Ububiko:

Rinda izuba ryinshi kandi ubike munsi ya 30 ℃

Hebei Veyong pharmaceutical Co., Ltd yashinzwe mu 2002, iherereye mu mujyi wa Shijiazhuang, Intara ya Hebei, mu Bushinwa, iruhande rw’umurwa mukuru wa Beijing.Ni ikigo kinini cyemewe na GMP cyemewe n’ibiyobyabwenge, hamwe na R&D, gukora no kugurisha amatungo ya APIs, imyiteguro, ibiryo byateganijwe hamwe ninyongeramusaruro.Nka Centre Tekinike yintara, Veyong yashyizeho uburyo bushya bwa R&D kumiti yubuvuzi bwamatungo, kandi nicyo kigo kizwi cyane mu guhanga udushya mu ikoranabuhanga rishingiye ku buvuzi bw’amatungo, hari abahanga mu bya tekinike 65.Veyong ifite ibishingwe bibiri: Shijiazhuang na Ordos, muri byo ikigo cya Shijiazhuang gifite ubuso bwa m2 78,706 m2, hamwe n’ibicuruzwa 13 bya API birimo Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, n'imirongo 11 yo gutegura harimo gutera inshinge, igisubizo cyo mu kanwa, ifu , premix, bolus, imiti yica udukoko hamwe na disinfectant, ects.Veyong itanga APIs, zirenga 100 bwite- label itegura, na serivisi ya OEM & ODM.

Veyong yita cyane ku micungire ya sisitemu ya EHS (Ibidukikije, Ubuzima & Umutekano), kandi yabonye impamyabumenyi ya ISO14001 na OHSAS18001.Veyong yashyizwe ku rutonde rw’inganda zigenda ziyongera mu Ntara ya Hebei kandi irashobora gutanga ibicuruzwa bikomeza.

Veyong yashyizeho uburyo bwuzuye bwo gucunga neza, yabonye icyemezo cya ISO9001, icyemezo cya GMP mu Bushinwa, icyemezo cya Ositarariya APVMA GMP, icyemezo cya Etiyopiya GMP, icyemezo cya Ivermectin CEP, kandi yatsinze igenzura rya FDA muri Amerika.Veyong ifite itsinda ryumwuga ryo kwiyandikisha, kugurisha na serivisi ya tekiniki, isosiyete yacu imaze kwiringira no gushyigikirwa nabakiriya benshi kubwiza bwibicuruzwa byiza, ubuziranenge bwiza mbere yo kugurisha na nyuma yo kugurisha, gucunga neza na siyansi.Veyong yakoze ubufatanye burambye n’inganda nyinshi zizwi cyane mu bya farumasi y’imiti n’ibicuruzwa byoherezwa mu Burayi, Amerika y'Epfo, Uburasirazuba bwo hagati, Afurika, Aziya, n'ibindi bihugu birenga 60.